Soluble_JJ
tumor_NN
necrosis_NN
factor_NN
receptors_NNS
inhibit_VBP
phorbol_NN
myristate_NN
acetate_NN
and_CC
cytokine-induced_JJ
HIV-1_NN
expression_NN
chronically_RB
infected_JJ
U1_NN
cells_NNS
._.

Recombinant_JJ
human_JJ
tumor_NN
necrosis_NN
factor_NN
-LRB-_-LRB-
TNF_NN
-RRB-_-RRB-
binding_NN
protein-1_NN
-LRB-_-LRB-
r-h_JJ
TBP-1_NN
-RRB-_-RRB-
and_CC
recombinant_JJ
human_JJ
soluble_JJ
dimeric_JJ
TNF_NN
receptor_NN
-LRB-_-LRB-
rhu_JJ
TNFR_NN
:_:
Fc_NN
-RRB-_-RRB-
were_VBD
used_VBN
to_TO
determine_VB
the_DT
relative_JJ
contributions_NNS
of_IN
TNF_NN
to_TO
phorbol_NN
myristate_NN
acetate_NN
-LRB-_-LRB-
PMA_NN
-RRB-_-RRB-
and_CC
cytokine-induced_JJ
human_JJ
immunodeficiency_NN
virus_NN
type_NN
1_CD
-LRB-_-LRB-
HIV-1_NN
-RRB-_-RRB-
replication_NN
in_IN
chronically_RB
infected_VBN
cell_NN
lines_NNS
._.

Treatment_NN
of_IN
HIV-1-infected_JJ
promonocytic_JJ
U1_NN
cells_NNS
with_IN
r-h-TBP-1_NN
or_CC
rhu_JJ
TNFR_NN
:_:
Fc_NN
reduced_VBD
PMA-induced_JJ
HIV-1_NN
p24_NN
antigen_NN
production_NN
in_IN
a_DT
concentration-dependent_JJ
manner_NN
,_,
with_IN
a_DT
maximal_JJ
inhibition_NN
of_IN
approximately_RB
90_CD
%_NN
._.

Maximal_JJ
inhibition_NN
of_IN
p24_NN
antigen_NN
production_NN
in_IN
T-lymphocytic_JJ
ACH-2_NN
cells_NNS
was_VBD
47_CD
%_NN
with_IN
r-hTBP-1_NN
and_CC
42_CD
%_NN
with_IN
rhu_JJ
TNFR_NN
:_:
Fc_NN
._.

r-hTBP-1_NN
and_CC
rhu_JJ
TNFR_NN
:_:
Fc_NN
also_RB
decreased_VBD
p24_NN
antigen_NN
synthesized_VBN
by_IN
U1_NN
cells_NNS
in_IN
response_NN
to_TO
other_JJ
stimuli_NNS
,_,
including_VBG
phytohemagglutinin_NN
-LRB-_-LRB-
PHA_NN
-RRB-_-RRB-
-_:
induced_JJ
supernatant_NN
,_,
granulocyte-macrophage_JJ
colony-stimulating_JJ
factor_NN
,_,
interleukin-6_NN
,_,
and_CC
TNF_NN
._.

Addition_NN
of_IN
r-hTBP-1_NN
to_TO
U1_NN
cells_NNS
during_IN
the_DT
last_JJ
4_CD
h_NN
of_IN
a_DT
24_CD
h_NN
incubation_NN
with_IN
PMA_NN
still_RB
inhibited_VBD
p24_NN
antigen_NN
production_NN
by_IN
15_CD
%_NN
._.

U1_NN
cells_NNS
stimulated_VBN
with_IN
10_CD
-LRB-_-LRB-
-7_CD
-RRB-_-RRB-
M_NN
PMA_NN
released_VBD
approximately_RB
1_CD
ng\/ml_NN
endogenous_JJ
TBP-1_NN
with_IN
an_DT
initial_JJ
peak_NN
observed_VBN
at_IN
1_CD
h_NN
and_CC
a_DT
second_JJ
peak_NN
at_IN
24_CD
h_NN
after_IN
PMA_NN
stimulation_NN
._.

r-hTBP-1_NN
also_RB
partially_RB
reversed_VBD
inhibition_NN
of_IN
U1_NN
cellular_JJ
proliferation_NN
caused_VBN
by_IN
PMA_NN
._.

Both_CC
r-hTBP-1_NN
and_CC
rhu_JJ
TNFR_NN
:_:
Fc_NN
blocked_VBD
PMA_NN
induction_NN
of_IN
nuclear_JJ
factor_NN
-LRB-_-LRB-
NK_NN
-RRB-_-RRB-
-_CC
kappa_NN
B_NN
DNA-binding_JJ
activity_NN
in_IN
U1_NN
cells_NNS
in_IN
association_NN
with_IN
decreases_NNS
in_IN
HIV-1_NN
replication_NN
._.

We_PRP
conclude_VBP
that_IN
soluble_JJ
TNF_NN
receptors_NNS
can_MD
inhibit_VB
stimuli-induced_JJ
HIV-1_NN
expression_NN
and_CC
NK-kappa_NN
B_NN
DNA-binding_JJ
activity_NN
in_IN
chronically_RB
infected_VBN
U1_NN
cells_NNS
._.

